Finally, we revealed a signaling mechanism through which BMP3 ligand bound to its receptor ActRIIB to activate SMAD-dependent and SMAD-independent TAK1/JNK pathways to suppress CRC development and progression. Here, MAPK8 is linked to colorectal carcinoma.